{"entity":{"type":"insider","cik":"0001809916","url":"/insider/0001809916","json_url":"/insider/0001809916.json","name":"Murugan Amar","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":15,"first":"2021-05-20","last":"2025-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Murugan Amar","source":"filing","n_filings":15,"first_seen":"2021-05-20","last_seen":"2025-03-19"}],"transactions":[{"id":4687465,"accession":"0001962918-25-000029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001962918-25-000029","line_url":"/filing/0001962918-25-000029#line-1","is_derivative":false,"issuer_cik":"0001809916","issuer_name":"ACELYRIN, Inc.","issuer_ticker":"SLRN","issuer_name_source":null,"issuer_url":"/issuer/0001809916","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3913.0,"shares_display":"3,913","price_per_share":2.744,"price_display":"2.74","price_state":"stated","total_value":10737.272,"total_display":"10,737.27","total_whole":"10,737","shares_owned_after":121587.0,"shares_owned_after_display":"121,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":2106806,"accession":"0000905148-24-002304","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-24-002304","line_url":"/filing/0000905148-24-002304","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1158.0,"shares_display":"1,158","price_per_share":6.629319516407599,"price_display":"6.63","price_state":"stated","total_value":7676.752,"total_display":"7,676.75","total_whole":"7,677","shares_owned_after":27108.0,"shares_owned_after_display":"27,108","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-20","scope":"insider","n_lines":3},{"id":2621913,"accession":"0000905148-24-001559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-001559","line_url":"/filing/0000905148-24-001559#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32401.0,"shares_display":"32,401","price_per_share":0.617,"price_display":"0.62","price_state":"stated","total_value":19991.417,"total_display":"19,991.42","total_whole":"19,991","shares_owned_after":695120.0,"shares_owned_after_display":"695,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":2579244,"accession":"0000905148-24-000909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-000909","line_url":"/filing/0000905148-24-000909#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10044.0,"shares_display":"10,044","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":7231.68,"total_display":"7,231.68","total_whole":"7,232","shares_owned_after":727521.0,"shares_owned_after_display":"727,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8645196,"accession":"0000905148-23-001511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-23-001511","line_url":"/filing/0000905148-23-001511#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8307.0,"shares_display":"8,307","price_per_share":0.389,"price_display":"0.39","price_state":"stated","total_value":3231.423,"total_display":"3,231.42","total_whole":"3,231","shares_owned_after":257084.0,"shares_owned_after_display":"257,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-20","scope":"insider"},{"id":8286141,"accession":"0001140361-23-040563","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-040563","line_url":"/filing/0001140361-23-040563","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8672.0,"shares_display":"8,672","price_per_share":1.6524176660516605,"price_display":"1.65","price_state":"stated","total_value":14329.766,"total_display":"14,329.77","total_whole":"14,330","shares_owned_after":269013.0,"shares_owned_after_display":"269,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-18","scope":"insider","n_lines":2},{"id":8286009,"accession":"0001140361-23-025560","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-23-025560","line_url":"/filing/0001140361-23-025560","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8389.0,"shares_display":"8,389","price_per_share":2.037117415663369,"price_display":"2.04","price_state":"stated","total_value":17089.378,"total_display":"17,089.38","total_whole":"17,089","shares_owned_after":271930.0,"shares_owned_after_display":"271,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider","n_lines":2},{"id":7908819,"accession":"0001567619-23-004539","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-23-004539","line_url":"/filing/0001567619-23-004539#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (SVP, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4221.0,"shares_display":"4,221","price_per_share":3.627,"price_display":"3.63","price_state":"stated","total_value":15309.567,"total_display":"15,309.57","total_whole":"15,310","shares_owned_after":279334.0,"shares_owned_after_display":"279,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":6112717,"accession":"0001140361-22-042379","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-042379","line_url":"/filing/0001140361-22-042379#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (SVP, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3612.0,"shares_display":"3,612","price_per_share":4.49,"price_display":"4.49","price_state":"stated","total_value":16217.88,"total_display":"16,217.88","total_whole":"16,218","shares_owned_after":127586.0,"shares_owned_after_display":"127,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-16","filed_date":"2022-11-18","scope":"insider"},{"id":6218613,"accession":"0001140361-22-030299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-030299","line_url":"/filing/0001140361-22-030299","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (SVP, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3430.0,"shares_display":"3,430","price_per_share":5.034651311953353,"price_display":"5.03","price_state":"stated","total_value":17268.854,"total_display":"17,268.85","total_whole":"17,269","shares_owned_after":131198.0,"shares_owned_after_display":"131,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider","n_lines":2},{"id":6324683,"accession":"0001140361-22-019990","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-019990","line_url":"/filing/0001140361-22-019990","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (SVP, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3223.0,"shares_display":"3,223","price_per_share":5.316281104560968,"price_display":"5.32","price_state":"stated","total_value":17134.374,"total_display":"17,134.37","total_whole":"17,134","shares_owned_after":134641.0,"shares_owned_after_display":"134,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider","n_lines":2},{"id":6604669,"accession":"0001140361-22-007763","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-22-007763","line_url":"/filing/0001140361-22-007763","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (SVP, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2577.0,"shares_display":"2,577","price_per_share":9.85656849049282,"price_display":"9.86","price_state":"stated","total_value":25400.377,"total_display":"25,400.38","total_whole":"25,400","shares_owned_after":138070.0,"shares_owned_after_display":"138,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-03","scope":"insider","n_lines":2},{"id":4108801,"accession":"0001567619-21-020779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-020779","line_url":"/filing/0001567619-21-020779#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (SVP, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2124.0,"shares_display":"2,124","price_per_share":17.1169,"price_display":"17.12","price_state":"stated","total_value":36356.2956,"total_display":"36,356.30","total_whole":"36,356","shares_owned_after":87540.0,"shares_owned_after_display":"87,540","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider"},{"id":5417728,"accession":"0001567619-21-016149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-016149","line_url":"/filing/0001567619-21-016149#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (SVP, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2080.0,"shares_display":"2,080","price_per_share":12.532,"price_display":"12.53","price_state":"stated","total_value":26066.56,"total_display":"26,066.56","total_whole":"26,067","shares_owned_after":89664.0,"shares_owned_after_display":"89,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":5250675,"accession":"0001209191-21-034426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034426","line_url":"/filing/0001209191-21-034426#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001809916","owner_name":"Murugan Amar","owner_display_name":"Murugan Amar","owner_url":"/insider/0001809916","role":"Officer (SVP, GC & Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, GC & Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, GC & Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5681.0,"shares_display":"5,681","price_per_share":14.55,"price_display":"14.55","price_state":"stated","total_value":82658.55,"total_display":"82,658.55","total_whole":"82,659","shares_owned_after":91744.0,"shares_owned_after_display":"91,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001962918","name":"ACELYRIN, Inc.","url":"/issuer/0001962918","role":"Officer (Chief Legal Officer)","n_filings":1,"first_seen":"2025-03-19","last_seen":"2025-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (EVP, Chief Legal Officer)","n_filings":14,"first_seen":"2021-05-20","last_seen":"2024-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001809916","retrieved_at":"2026-08-23T07:48:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}